Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-10

Clinical Trial Update: Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating ezetimibe's effects on postprandial hyperlipidemia and endothelial function in metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: UMC Utrecht | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED